CADTH Canadian Drug Expert Committee recommendation. indication: Type 1 Gaucher disease. Eliglustat (Cerdelga -- Sanofi Genzyme) :

Saved in:

Bibliographic Details
Online Access:	http://www.ncbi.nlm.nih.gov/books/NBK534706/ Full text
Corporate Author:	CADTH Canadian Drug Expert Committee (Author)
Format:	Electronic eBook
Language:	English
Published:	Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2017
Edition:	Version 1.0.
Series:	Common drug review clinical review report.
Subjects:	Gaucher Disease > drug therapy. Cytochrome P-450 CYP2D6 Inhibitors > therapeutic use. Enzyme Replacement Therapy > economics. Insurance, Health, Reimbursement > economics. Drug Costs. Cost-Benefit Analysis. Canada.

Internet